000 01338 a2200325 4500
005 20250518033802.0
264 0 _c20200610
008 202006s 0 0 eng d
022 _a1744-8395
024 7 _a10.1080/14760584.2019.1605906
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDasari, Vijayendra
245 0 0 _aProphylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical development.
_h[electronic resource]
260 _bExpert review of vaccines
_c05 2019
300 _a457-474 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aEpstein-Barr Virus Infections
_xcomplications
650 0 4 _aHerpesvirus 4, Human
_ximmunology
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aLymphoproliferative Disorders
_xprevention & control
650 0 4 _aNasopharyngeal Carcinoma
_xprevention & control
650 0 4 _aNasopharyngeal Neoplasms
_xprevention & control
650 0 4 _aViral Vaccines
_ximmunology
700 1 _aSinha, Debottam
700 1 _aNeller, Michelle A
700 1 _aSmith, Corey
700 1 _aKhanna, Rajiv
773 0 _tExpert review of vaccines
_gvol. 18
_gno. 5
_gp. 457-474
856 4 0 _uhttps://doi.org/10.1080/14760584.2019.1605906
_zAvailable from publisher's website
999 _c29591056
_d29591056